Nippon India Pharma Fund vs Kotak Healthcare Fund compare
Kotak Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹481 Cr | ₹8346 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 11 Dec 2023 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.39 | 1.82 |
| Manager | Abhishek Bisen | Sailesh Raj Bhan |
| ISIN Code | INF174KA1PW4 | INF204K01968 |
| Exits Load | Kotak Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -1.87% | -0.42% |
| 6 Month | 3.37% | 1.31% |
| 1 Year | -3.81% | -0.53% |
| 3 Year | - | 20.97% |
| 5 Year | - | 16.1% |
SIP Return Analysis
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | -0.03% | 0.75% |
| 1 Year | 4.67% | 6.3% |
| 3 Year | - | 16.99% |
| 5 Year | - | 16.43% |
Rolling Lumpsum Returns
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 13.51% | 16.7% |
| 3 Year | - | 20.91% |
| 5 Year | - | 20.41% |
Risk Management
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 14.36% |
| Sharp | - | 0.98% |
| Beta | - | 0.87% |
| Alpha | - | 1.45% |
Fund Managers
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Abhishek Bisen | Sailesh Raj Bhan |
| Total AUM | ₹0 Cr | ₹96086 Cr |
| Funds Managed | 33 | 5 |
| Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 10.31 | 1.24 |
| Large Cap | 27.75 | 32.65 |
| Mid Cap | 32.05 | 35.11 |
| Small Cap | 29.89 | 31 |
Sector Allocation
| Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.28 | 0.34 |
| Basic Materials | 3.23 | - |
| Healthcare | 95.49 | 99.66 |
Top Comparisons
ICICI Prudential Technology Fund - Growth
3Y Returns13.8%
Nippon India Nifty IT Index Fund - Reg (G)
3Y Returns0%
SBI US Specific Equity Active FoF - Regular Plan - Growth
3Y Returns24.77%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns12.36%
HSBC Global Equity Climate Change Fund of Fund - Regular - Growth
3Y Returns8.19%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns12.36%
DSP World Mining Overseas Equity Omni FOF - Regular Plan - Growth
3Y Returns14.81%
Axis Global Equity Alpha Fund of Fund - Regular Plan - Growth Option
3Y Returns21%